跳至主要内容
临床试验/NCT04741308
NCT04741308Unknown不适用

The Effect of Cognitive Behavior Therapy (CBT) on Psychological Status and Immune Function of Colorectal Cancer Patients Undergoing Chemotherapy.

Shanghai 10th People's Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Change from baseline immune function at follow-up.

研究概览

简要总结

To explore the effect of CBT on psychological status of colorectal cancer patients undergoing chemotherapy. To explore the effect of CBT on immune function of colorectal cancer patients undergoing chemotherapy.

详细描述

Cancer patients undergoing chemotherapy are often subjected to considerable psychological stress. CBT is considered as one of the effective methods to relieve stress. CBT is effective in alleviating depression and anxiety, but the effect of CBT on cognitive and immune function in patients with colorectal cancer undergoing chemotherapy remains uninvestigated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1.18≤age≤75; 2.Being scheduled to undergo colorectal cancer surgery; 3.Being able to complete all the assessment.

排除标准

  • Having a history of tumor, mental disorders(including dementia), brain trauma or other cerebral diseases;
  • Having severe depression and anxiety currently;
  • Having alcohol dependence or other substance dependence;
  • Having serious physical illness;
  • Participating in other clinical studies.

结局指标

主要结局

Change from baseline immune function at follow-up.

时间窗: Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).

Immune function assessment includes cytokine levels (IL-1α, IL-1β, IL-6, IL-8, TNF-α, TNF-β, CRP) and immune cell levels (CD4+T cell, CD8+T cell, natural killer, monocytes, B cell).

Change from baseline depressionat at follow-up.

时间窗: Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).

Depression will be assessed by Patient Health Questionnaire (PHQ-9). The sum score of PHQ-9 ranges from 0 to 27. Higher scores mean a worse outcome.

Change from baseline cognitive function at follow-up.

时间窗: Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).

Cognitive function will be assessed by Mini-mental State Examination (MMSE), Hopkins Verbal Learning Test-Revised, Digit Span Test, Digit-symbol Test and Trail Making Test.

Change from baseline anxiety at follow-up.

时间窗: Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).

Anxiety will be assessed by Generalized Anxiety Disorder (GAD-7). The sum score of GAD-7 ranges from 0 to 21. Higher scores mean a worse outcome.

Change from baseline stress perception at follow-up.

时间窗: Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).

Stress perception will be assessed by Perceived Stress Scale (PSS-10). The sum score of PSS-10 ranges from 0 to 40. Higher scores mean a worse outcome.

次要结局

  • Change from baseline quality of life of patient at follow-up.(Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).)
  • Change from baseline sleep quality at follow-up.(Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).)
  • Social support(Baseline.)
  • Change from baseline chemotherapy response at follow-up.(Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).)
  • Change from baseline self efficacy at follow-up.(Baseline and follow-up ( immediately after intervention, 3 months and 6 months after intervention).)

研究者

发起方
Shanghai 10th People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuan Shen, MD, PhD

Chief of Psychiatry

Shanghai 10th People's Hospital

研究点 (1)

Loading locations...

相似试验